RUNX2 and periodontitis: In a rat model of experimental ligature-induced periodontitis, montelukast significantly reduced alveolar bone loss and gingival myeloperoxidase and increased Runt-related transcription factor 2 expression, indicating that the drug might alleviate periodontal inflammation [140].